Amylin Therapies: What's on the Horizon for Obesity and Meta

Name: Amylin Therapies: What's on the Horizon for Obesity and Metabolic Care?
Uploaded: 2026-10-06T04:00:00+00:00
Duration: 3 min 24 s
Description: What could amylin-based therapies bring to the next generation of obesity care? From EASD 2026 in Milan, Dr. Timothy Garvey explores the evolving science b

Media formats available:

Ready to Claim Your Credits?

You have attempts to pass this post-test. Take your time and review carefully before submitting.

Good luck!

EASD 2026: The Importance of Protecting Lean Muscle Mass in Managing Patients With Obesity
EASD 2026: The Importance of Protecting Lean Muscle Mass in Managing Patients With Obesity
Endocrinology
EASD 2026: The Importance of Protecting Lean Muscle Mass in Managing Patients With Obesity
Stefan D. Anker, MD, PhD
Stefan D. Anker, MD, PhD
Connecting the Dots in Obesity Care: Key Takeaways From EASD 2026
Connecting the Dots in Obesity Care: Key Takeaways From EASD 2026
Endocrinology
Connecting the Dots in Obesity Care: Key Takeaways From EASD 2026
Elisabeth Van Rossum, MD, PhD; William Mencia, MD, FACEHP
Elisabeth Van Rossum, MD, PhD; William Mencia, MD, FACEHP
Changing the Trajectory: Why Earlier Obesity Treatment Matters
Changing the Trajectory: Why Earlier Obesity Treatment Matters
Endocrinology
Changing the Trajectory: Why Earlier Obesity Treatment Matters
Elisabeth Van Rossum, MD, PhD; William Mencia, MD, FACEHP
Elisabeth Van Rossum, MD, PhD; William Mencia, MD, FACEHP
TRIUMPH-2: Translating New Obesity Data Into Real-World Care
TRIUMPH-2: Translating New Obesity Data Into Real-World Care
Endocrinology
TRIUMPH-2: Translating New Obesity Data Into Real-World Care
Elisabeth Van Rossum, MD, PhD; William Mencia, MD, FACEHP
Elisabeth Van Rossum, MD, PhD; William Mencia, MD, FACEHP

Amylin Therapies: What's on the Horizon for Obesity and Metabolic Care?

Recommended

Title